Detail of > 54613-99-9
- CAS Number:
- 54613-99-9
- Name:
N-Boc-N'-(2-chlorobenzyloxycarbonyl)-L-lysine
- Formula:
- C19H27ClN2O6
- Molecular Structure:
- Synonyms:
- Boc-Lys(2-Cl-Z) )-OH;Boc-Lys(2Cl-Z)-OH;N-Boc-N'-(2- chlorobenzyloxy-carbonyl) -L-lysine;Boc-Lys(2-Cl-Cbz)-OH;Boc-Lys(Cl-Z)-OH;Boc-L-Lys(2-Cl-Z)-OH;N-Boc-N-(2-chlorobenzyloxycarbonyl)-L-lysine;Boc-Lys(2-chloro-z);Boc-L-Lys(2-Cl-CBZ)-OH;
- Molecular Weight:
- 414.88
- Density:
- 1.236 g/cm3
- Melting Point:
- 70-73 °C
- Boiling Point:
- 608.3 °C at 760 mmHg
- Flash Point:
- 321.7 °C
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety:
- S26;S36Details
- Deleted CAS:
- 92086-68-5|62526-69-6|60242-83-3
Related products
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(17)
Hong Kong(1)
United Kingdom(1)
United States(1)
- Business Type:
- Importer/Exporter(13)Lab/Research institutions(2)Other(2)Manufacturers(1)
- Certificates:
- ISO(2)Production License(1)QS(1)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Preparation of decapeptide with human interleukin-1-like activity
- Preparation of decapeptide with human interleukin-1-like activity. Hirose, Toshihiro; Yasuda, Shuhei; Furuichi, Kiyoshi (Yamanouchi Pharmaceutical Co., Ltd., Japan). Jpn. Kokai Tokkyo Koho JP 03271300 A2 3 Dec 1991 Heisei, 6 pp.Some commonly used reagents like 30924-93-7 and 54613-99-9 are used in this experiment. (Japan). CODEN: JKXXAF. CLASS: ICM: C07K007-06. ICA: A61K037-02. ICI: C07K099-00. APPLICATION: JP 90-70358 19 Mar 1990. DOCUMENT TYPE: Patent CA Section: 34 (Amino Acids, Peptides, and Proteins) Section cross-reference(s): 1 H-Ala-Leu-Gly-Leu-Lys-Glu-Lys-Asn-Leu-Tyr-OH (I) or its esters, amides, acylated derivs., or salts, which enhance interleukin-1 formation, enhance antibody formation, activate colony-stimulating factor, inhibit pyrexia, reduce PGE2 formation (no data), and are useful as anti-infective, anti-inflammatory, and immunostimulating agents, are prepd. Na-tert-Butoxycarbonyl-O-(bromobenzyloxycarbonyl)-L-tyrosine immobilized to resin support was successively coupled with protected amino acids and deprotected in a usual manner to give I.CF3CO2H, which strongly enhanced Con A-induced thymus cell division. .
- Peptides
- Peptides. Aoki, Nobuo; Tamaki, Taro (Kowa Co., Ltd. , Japan). Eur. 54613-99-9 are also occured in this study. Pat. Appl. EP 121995 A2 17 Oct 1984, 16 pp. DESIGNATED STATES: R: CH, DE, FR, GB, LI. (English). (European Patent Organization). CODEN: EPXXDW. CLASS: IC: C07C103-52; A61K037-02. 54613-99-9 is the cas registry number of certain chemical which is used as reagents here. APPLICATION: EP 84-301123 22 Feb 1984. PRIORITY: JP 83-38564 9 Mar 1983. DOCUMENT TYPE: Patent CA Section: 34 (Amino Acids, Peptides, and Proteins) Section cross-reference(s): 1, 6 a2-Plasmin inhibitor (a2-PI) N-terminal-related peptides H-Asn-Glu(R)-Gln-Val-Ser-Pro-Leu-Thr-Gly-Leu-Lys-NH2 (I; R = NH2 or chromophore group) were prepd. as agents for the treatment of hemostatic disorders and thrombosis. Thus, I (R = NH2) (II) was prepd. by the solid-phase method on a benzhydrylamine resin. II inhibited the crosslinking of a2-PI to fibrin, and II accelerated fibrinolysis. ..
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.：Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620